| Stage | NOV | % of rev | WDAY | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.2B | 100.00% | $2.6B | 100.00% | WDAY ×1.19 |
| Gross profit | $439M | 19.72% | $2.0B | 75.39% | WDAY +55.7pp |
| Operating income | $142M | 6.38% | $313M | 11.82% | WDAY +5.4pp |
| Pre-tax income | $123M | 5.53% | $327M | 12.34% | WDAY +6.8pp |
| Net income | $95M | 4.27% | $632M | 23.86% | WDAY +19.6pp |
| Stage | NOV | WDAY | Gap · A − B |
|---|---|---|---|
| Revenue | $2.2B100.00% | $2.6B100.00% | WDAY ×1.19 |
| Gross profit | 19.72%$439M | 75.39%$2.0B | WDAY +55.7pp |
| Operating income | 6.38%$142M | 11.82%$313M | WDAY +5.4pp |
| Pre-tax income | 5.53%$123M | 12.34%$327M | WDAY +6.8pp |
| Net income |
| 4.27%$95M |
| 23.86%$632M |
| WDAY +19.6pp |
None
No disclosed counterparties: NOV.